{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:10:26Z","timestamp":1790669426185,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,8,31]]},"DOI":"10.1038\/onc.2017.131","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T15:04:42Z","timestamp":1493651082000},"page":"5023-5034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells"],"prefix":"10.1038","volume":"36","author":[{"given":"J","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"BFonc2017131_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00185107","volume":"35","author":"C Traversari","year":"1992","unstructured":"Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992; 35: 145\u2013152.","journal-title":"Immunogenetics"},{"key":"BFonc2017131_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P Vanderbruggen","year":"1991","unstructured":"Vanderbruggen P, Traversari C, Chomez P, Lurquin C, Deplaen E, Vandeneynde B et al. A gene encoding an antigen recognized by cytolytic lymphocytes-T on a human-melanoma. Science 1991; 254: 1643\u20131647.","journal-title":"Science"},{"key":"BFonc2017131_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2012.05.031","volume":"325","author":"MF Ladelfa","year":"2012","unstructured":"Ladelfa MF, Peche LY, Toledo MF, Laiseca JE, Schneider C, Monte M . Tumor-specific MAGE proteins as regulators of p53 function. Cancer Lett 2012; 325: 11\u201317.","journal-title":"Cancer Lett"},{"key":"BFonc2017131_CR4","doi-asserted-by":"publisher","first-page":"46120","DOI":"10.18632\/oncotarget.10028","volume":"7","author":"K Kloudova","year":"2016","unstructured":"Kloudova K, Hromadkova H, Partlova S, Brtnicky T, Rob L, Bartunkova J et al. Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines. Oncotarget 2016; 7: 46120\u201346126.","journal-title":"Oncotarget"},{"key":"BFonc2017131_CR5","first-page":"6682","volume":"61","author":"M Otte","year":"2001","unstructured":"Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Loning T, Janicke F et al. MAGE-A gene expression pattern in primary breast cancer. Cancer Res 2001; 61: 6682\u20136687.","journal-title":"Cancer Res"},{"key":"BFonc2017131_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3325\/cmj.2011.52.171","volume":"52","author":"B Matkovic","year":"2011","unstructured":"Matkovic B, Juretic A, Spagnoli GC, Separovic V, Gamulin M, Separovic R et al. Expression of MAGE-A and NY-ESO-1 cancer\/testis antigens in medullary breast cancer: retrospective immunohistochemical study. Croat Med J 2011; 52: 171\u2013177.","journal-title":"Croat Med J"},{"key":"BFonc2017131_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12032-014-0285-0","volume":"31","author":"EA Abd-Elsalam","year":"2014","unstructured":"Abd-Elsalam EA, Ismaeil NA . Melanoma-associated antigen genes: a new trend to predict the prognosis of breast cancer patients. Med Oncol 2014; 31: 285.","journal-title":"Med Oncol"},{"key":"BFonc2017131_CR8","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1073\/pnas.86.21.8227","volume":"86","author":"RD Larsen","year":"1989","unstructured":"Larsen RD, Rajan VP, Ruff MM, Kukowska-Latallo J, Cummings RD, Lowe JB . Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer. Proc Natl Acad Sci USA 1989; 86: 8227\u20138231.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017131_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2017131_CR10","doi-asserted-by":"publisher","first-page":"2498764","DOI":"10.1155\/2016\/2498764","volume":"2016","author":"A Acar","year":"2016","unstructured":"Acar A, Simoes BM, Clarke RB, Brennan K . A role for notch signalling in breast cancer and endocrine resistance. Stem Cells Int 2016; 2016: 2498764.","journal-title":"Stem Cells Int"},{"key":"BFonc2017131_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/bcr3447","volume":"15","author":"V Bolos","year":"2013","unstructured":"Bolos V, Mira E, Martinez-Poveda B, Luxan G, Canamero M, Martinez C et al. Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res 2013; 15: 15.","journal-title":"Breast Cancer Res"},{"key":"BFonc2017131_CR12","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","volume":"22","author":"BJ Nickoloff","year":"2003","unstructured":"Nickoloff BJ, Osborne BA, Miele L . Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 2003; 22: 6598\u20136608.","journal-title":"Oncogene"},{"key":"BFonc2017131_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","volume":"66","author":"S Stylianou","year":"2006","unstructured":"Stylianou S, Clarke RB, Brennan K . Aberrant activation of Notch signaling in human breast cancer. Cancer Res 2006; 66: 1517\u20131525.","journal-title":"Cancer Res"},{"key":"BFonc2017131_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray SJ . Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678\u2013689.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2017131_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.devcel.2009.03.010","volume":"16","author":"ME Fortini","year":"2009","unstructured":"Fortini ME . Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009; 16: 633\u2013647.","journal-title":"Dev Cell"},{"key":"BFonc2017131_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2011.03.012","volume":"307","author":"B Bao","year":"2011","unstructured":"Bao B, Wang ZW, Ali S, Kong DJ, Li YW, Ahmad A et al. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011; 307: 26\u201336.","journal-title":"Cancer Lett"},{"key":"BFonc2017131_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/978-1-4614-0899-4_14","volume":"727","author":"YY Hu","year":"2012","unstructured":"Hu YY, Zheng MH, Zhang R, Liang YM, Han H . Notch signaling pathway and cancer metastasis. Adv Exp Med Biol 2012; 727: 186\u2013198.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc2017131_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","volume":"36","author":"SK Saha","year":"2017","unstructured":"Saha SK, Choi HY, Kim BW, Dayem AA, Yang GM, Kim KS et al. KRT19 directly interacts with beta-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene 2017; 36: 332\u2013349.","journal-title":"Oncogene"},{"key":"BFonc2017131_CR19","doi-asserted-by":"publisher","first-page":"34371","DOI":"10.1074\/jbc.M101343200","volume":"276","author":"N Gupta-Rossi","year":"2001","unstructured":"Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 2001; 276: 34371\u201334378.","journal-title":"J Biol Chem"},{"key":"BFonc2017131_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccr.2009.01.007","volume":"15","author":"CH Pui","year":"2009","unstructured":"Pui CH . T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome. Cancer Cell 2009; 15: 85\u201387.","journal-title":"Cancer Cell"},{"key":"BFonc2017131_CR21","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.1128\/MCB.21.21.7403-7415.2001","volume":"21","author":"GY Wu","year":"2001","unstructured":"Wu GY, Lyapina S, Das I, Li JH, Gurney M, Pauley A et al. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 2001; 21: 7403\u20137415.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017131_CR22","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/nar\/gkh735","volume":"32","author":"S Laduron","year":"2004","unstructured":"Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res 2004; 32: 4340\u20134350.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017131_CR23","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1128\/MCB.20.7.2400-2410.2000","volume":"20","author":"SF Zhou","year":"2000","unstructured":"Zhou SF, Fujimuro M, Hsieh JJD, Chen L, Miyamoto A, Weinmaster G et al. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC to facilitate NotchIC function. Mol Cell Biol 2000; 20: 2400\u20132410.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017131_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/geno.1998.5638","volume":"55","author":"E De Plaen","year":"1999","unstructured":"De Plaen E, De Backer O, Arnaud D, Bonjean B, Chomez P, Martelange V et al. A new family of mouse genes homologous to the human MAGE genes. Genomics 1999; 55: 176\u2013184.","journal-title":"Genomics"},{"key":"BFonc2017131_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/ctrv.1999.0126","volume":"25","author":"AM Gillespie","year":"1999","unstructured":"Gillespie AM, Coleman RE . The potential of melanoma antigen expression in cancer therapy. Cancer Treat Rev 1999; 25: 219\u2013227.","journal-title":"Cancer Treat Rev"},{"key":"BFonc2017131_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrc1075","volume":"3","author":"P Friedl","year":"2003","unstructured":"Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362\u2013374.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017131_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"D Bell","year":"2011","unstructured":"Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F et al. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2017131_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RYJ, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFonc2017131_CR29","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J . EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741\u20134751.","journal-title":"Oncogene"},{"key":"BFonc2017131_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.genet.30.1.405","volume":"30","author":"M Hochstrasser","year":"1996","unstructured":"Hochstrasser M . Ubiquitin-dependent protein degradation. Annu Rev Genet 1996; 30: 405\u2013439.","journal-title":"Annu Rev Genet"},{"key":"BFonc2017131_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","volume":"70","author":"CM Pickart","year":"2001","unstructured":"Pickart CM . Mechanisms underlying ubiquitination. Annu Rev Biochem 2001; 70: 503\u2013533.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2017131_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","volume":"39","author":"JM Doyle","year":"2010","unstructured":"Doyle JM, Gao J, Wang J, Yang M, Potts PR . MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 2010; 39: 963\u2013974.","journal-title":"Mol Cell"},{"key":"BFonc2017131_CR33","doi-asserted-by":"publisher","first-page":"42028","DOI":"10.18632\/oncotarget.5973","volume":"6","author":"JQ Hao","year":"2015","unstructured":"Hao JQ, Song X, Wang JJ, Guo CL, Li Y, Li B et al. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E. Oncotarget 2015; 6: 42028\u201342039.","journal-title":"Oncotarget"},{"key":"BFonc2017131_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015; 12: 445\u2013464.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2017131_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1574888X11666161028143224","volume":"12","author":"G Shukla","year":"2017","unstructured":"Shukla G, Khera HK, Srivastava AK, Khare P, Patidar R, Saxena R . Therapeutic potential, challenges and future perspective of cancer stem cells in translational oncology: a critical review. Curr Stem Cell Res Ther 2017; 12: 207\u2013224.","journal-title":"Curr Stem Cell Res Ther"},{"key":"BFonc2017131_CR36","first-page":"267","volume":"20","author":"M Brzozowa-Zasada","year":"2016","unstructured":"Brzozowa-Zasada M, Piecuch A, Dittfeld A, Mielanczyk L, Michalski M, Wyrobiec G et al. Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn) 2016; 20: 267\u2013272.","journal-title":"Contemp Oncol (Pozn)"},{"key":"BFonc2017131_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","volume":"37","author":"JL Weon","year":"2015","unstructured":"Weon JL, Potts PR . The MAGE protein family and cancer. Curr Opin Cell Biol 2015; 37: 1\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2017131_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2407-10-163","volume":"10","author":"S Zhang","year":"2010","unstructured":"Zhang S, Zhou X, Yu H, Yu Y . Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines. BMC Cancer 2010; 10: 163.","journal-title":"BMC Cancer"},{"key":"BFonc2017131_CR39","doi-asserted-by":"publisher","first-page":"e104099","DOI":"10.1371\/journal.pone.0104099","volume":"9","author":"S Daudi","year":"2014","unstructured":"Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A et al. Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer. PloS One 2014; 9: e104099.","journal-title":"PloS One"},{"key":"BFonc2017131_CR40","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bbrc.2016.03.161","volume":"473","author":"D Wang","year":"2016","unstructured":"Wang D, Wang JY, Ding N, Li YJ, Yang YR, Fang XD et al. MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation. Biochem Biophys Res Commun 2016; 473: 959\u2013965.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2017131_CR41","doi-asserted-by":"publisher","first-page":"e0127713","DOI":"10.1371\/journal.pone.0127713","volume":"10","author":"L Marcar","year":"2015","unstructured":"Marcar L, Ihrig B, Hourihan J, Bray SE, Quinlan PR, Jordan LB et al. MAGE-A cancer\/testis antigens inhibit MDM2 ubiquitylation function and promote increased levels of MDM4. PloS One 2015; 10: e0127713.","journal-title":"PloS One"},{"key":"BFonc2017131_CR42","doi-asserted-by":"publisher","first-page":"34793","DOI":"10.1074\/jbc.M109.065979","volume":"284","author":"EB Askew","year":"2009","unstructured":"Askew EB, Bai SX, Hnat AT, Minges JT, Wilson EM . Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators. J Biol Chem 2009; 284: 34793\u201334808.","journal-title":"J Biol Chem"},{"key":"BFonc2017131_CR43","doi-asserted-by":"publisher","first-page":"10362","DOI":"10.1158\/0008-5472.CAN-10-1341","volume":"70","author":"L Marcar","year":"2010","unstructured":"Marcar L, Maclaine NJ, Hupp TR, Meek DW . Mage-A cancer\/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res 2010; 70: 10362\u201310370.","journal-title":"Cancer Res"},{"key":"BFonc2017131_CR44","doi-asserted-by":"publisher","first-page":"11160","DOI":"10.1073\/pnas.0510834103","volume":"103","author":"M Monte","year":"2006","unstructured":"Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, Pierotti MA et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci USA 2006; 103: 11160\u201311165.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017131_CR45","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/cdd.2011.173","volume":"19","author":"LY Peche","year":"2012","unstructured":"Peche LY, Scolz M, Ladelfa MF, Monte M, Schneider C . MageA2 restrains cellular senescence by targeting the function of PMLIV\/p53 axis at the PML-NBs. Cell Death Differ 2012; 19: 926\u2013936.","journal-title":"Cell Death Differ"},{"key":"BFonc2017131_CR46","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/carcin\/bgs236","volume":"33","author":"HY Tseng","year":"2012","unstructured":"Tseng HY, Chen LH, Ye Y, Tay KH, Jiang CC, Guo ST et al. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells. Carcinogenesis 2012; 33: 1871\u20131881.","journal-title":"Carcinogenesis"},{"key":"BFonc2017131_CR47","doi-asserted-by":"publisher","first-page":"28546","DOI":"10.1074\/jbc.M102075200","volume":"276","author":"O Potapova","year":"2001","unstructured":"Potapova O, Basu S, Mercola D, Holbrook NJ . Protective role for c-Jun in the cellular response to DNA damage. J Biol Chem 2001; 276: 28546\u201328553.","journal-title":"J Biol Chem"},{"key":"BFonc2017131_CR48","first-page":"1343","volume":"62","author":"QB She","year":"2002","unstructured":"She QB, Chen N, Bode AM, Flavell RA, Dong Z . Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 2002; 62: 1343\u20131348.","journal-title":"Cancer Res"},{"key":"BFonc2017131_CR49","doi-asserted-by":"publisher","first-page":"13123","DOI":"10.1073\/pnas.0504170102","volume":"102","author":"M Uhlirova","year":"2005","unstructured":"Uhlirova M, Jasper H, Bohmann D . Non-cell-autonomous induction of tissue overgrowth by JNK\/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci USA 2005; 102: 13123\u201313128.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017131_CR50","first-page":"2833","volume":"61","author":"HL Kim","year":"2001","unstructured":"Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA et al. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res 2001; 61: 2833\u20132837.","journal-title":"Cancer Res"},{"key":"BFonc2017131_CR51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1016-8478(23)12876-7","volume":"21","author":"LE Heasley","year":"2006","unstructured":"Heasley LE, Han SY . JNK regulation of oncogenesis. Mol Cells 2006; 21: 167\u2013173.","journal-title":"Mol Cells"},{"key":"BFonc2017131_CR52","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/cas.13026","volume":"107","author":"S Kitade","year":"2016","unstructured":"Kitade S, Onoyama I, Kobayashi H, Yagi H, Yoshida S, Kato M et al. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors. Cancer Sci 2016; 107: 1399\u20131405.","journal-title":"Cancer Sci"},{"key":"BFonc2017131_CR53","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/anr.1780321212","volume":"32","author":"M Weinberger","year":"1989","unstructured":"Weinberger M, Tierney WM, Booher P, Katz BP . Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial. Arthritis Rheum 1989; 32: 1577\u20131583.","journal-title":"Arthritis Rheum"},{"key":"BFonc2017131_CR54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/15384101.2014.1000112","volume":"14","author":"L Kozakova","year":"2015","unstructured":"Kozakova L, Vondrova L, Stejskal K, Charalabous P, Kolesar P, Lehmann AR et al. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex. Cell Cycle 2015; 14: 920\u2013930.","journal-title":"Cell Cycle"},{"key":"BFonc2017131_CR55","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1074\/jbc.M112.428409","volume":"288","author":"JT Minges","year":"2013","unstructured":"Minges JT, Su SF, Grossman G, Blackwelder AJ, Pop EA, Mohler JL et al. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. J Biol Chem 2013; 288: 1939\u20131952.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T21:39:40Z","timestamp":1719178780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":55,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017,8,31]]}},"alternative-id":["BFonc2017131"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.131","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,1]]},"assertion":[{"value":"8 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}